HER2 Advisory Board – Patients Needed
 

HER2 Advisory Board – Patients Needed

Genentech is seeking patients with early or metastatic breast cancer who have been on or are currently taking Herceptin (trastuzumab), Perjeta (pertuzumab) and/or Kadcyla (ado-trastuzumab emtansine or T-DM1). They will be hosting two advisory boards to include the patient perspective in the planning process for HER2 and equip patients with knowledge about HER2 therapies. Please reach out to their coordinating agency for additional information by emailing Jana Ross at jross@webershandwick.com.

Re: HER2 Advisory Board – Patients Needed
 

I emailed Ms Ross last week. She emailed me back yesterday and said it was full. I tried.

Re: HER2 Advisory Board – Patients Needed
 

I am only stage III and my email was replied to requesting additional information so perhaps they still have room for earlier stage cancer. I would participate given this drug may be saving my life.

Re: HER2 Advisory Board – Patients Needed
 

did anyone get picked to do this????

Re: HER2 Advisory Board – Patients Needed
 

Yes, I did. First meeting is next month. Will do my best to represent!

Re: HER2 Advisory Board – Patients Needed
 

Flori,
Can't think of anyone I'd rather have represent me!
You go girl!
Denise